IFF June 2025 Newsletter


Lab Updates

Evening of Inspiration Sponsorships



IFF Updates

We are excited to share the advancements of the work with prestigious labs at University of Michigan and New York University that Ian's Friend's Foundation has supported with your incredible generosity. Without your support, funding the research to keep our mission in eradicating pediatric brain cancer would not be possible.

Everyday we strive to make a dIFFerence.

IFF - NeuroSlides Consortium:

Advancing AI for Pediatric Brain Tumors

The IFF-NeuroSlides Consortium brings together the University of Michigan’s Machine Learning in Neurosurgery Lab and Ian’s Friends Foundation to assemble the most comprehensive digital pathology resource ever created for pediatric brain tumors.


Leveraging Ian’s Friends Foundation’s tissue-banking network, we are digitizing and harmonizing >20,000 whole-slide images (WSIs) from more than 2,000 children across the full WHO diagnostic spectrum — from diffuse and circumscribed gliomas to embryonal, pineal, and metastatic tumors.


Each case is accompanied by a rich panel of histochemical and immunohistochemical stains, and our pipeline includes algorithmic stain alignment that lets us analyze multi-stain biology as a single 3-D “stack” of data points. These slides, together with corresponding MRI and curated clinical metadata, form the backbone of a secure, de-identified research dataset ready for large-scale AI development.


Building on this unprecedented dataset, we are training a suite of state-of-the-art deep-learning models under the umbrella name NeuroSlides-AI.


Core objectives include:

(i) coarse-to-fine tumor subtype classification,

(ii) cross-stain representation learning that transfers knowledge from rare IHC stains back to routine H&E,

(iii) prediction of driver mutations and patient survival directly from tissue morphology, and

(iv) “virtual staining” and automated pathology-report generation to streamline clinical workflows.


By unifying histology with MRI and outcome data, the consortium aims to accelerate biomarker discovery, refine treatment stratification, and ultimately improve the lives of children with brain tumors—precisely the mission at the heart of Ian’s Friends Foundation.


IFF supported NYU researcher and lab is showing great promise in researching HiC to detect gene fusions

NYU research team led by Dr. Kristyn Galbraith and Dr. Matija Snuderl has developed and validated a new method for identifying genetic changes in solid tumors. The researchers used a novel technique called high-throughput chromosome conformation capture (HiC) to detect gene fusions and rearrangements, which are critical for cancer development and progression.


HiC allows for more accurate and comprehensive genetic analysis of tumor samples, potentially leading to better diagnosis and treatment options for cancer patients. Using this novel method, they were able to find therapeutic targets in previously negative samples, expanding precision medicine approaches for patients with brain and other tumors.


Evening of Inspiration

We are once again excited to announce our annual Evening of Inspiration events in Los Angeles and Atlanta.

IFF is able to support groundbreaking research only because of the generous support of our community.


All sponsorships committed by August 10, 2025 will be included on invitation



Sponsors committed by August 10, 2025 will be included in Newsletters.

Facebook  X  Instagram